Workboat Indexes
Articles published by Exelixis, Inc.
![](https://mms.businesswire.com/media/20220104005214/en/610803/5/exelixis_id_rgb_2c.jpg)
![](https://mms.businesswire.com/media/20211217005072/en/610803/5/exelixis_id_rgb_2c.jpg)
Exelixis Elects Jacqueline Wright to Its Board of Directors
December 17, 2021
From Exelixis, Inc.
Via Business Wire
Tickers
EXEL
![](https://mms.businesswire.com/media/20211214006098/en/611316/5/Exelixis_Logo_JPG.jpg)
![](https://mms.businesswire.com/media/20211120005130/en/611316/5/Exelixis_Logo_JPG.jpg)
![](https://mms.businesswire.com/media/20211109005494/en/611316/5/Exelixis_Logo_JPG.jpg)
![](https://mms.businesswire.com/media/20211103006038/en/610803/5/exelixis_id_rgb_2c.jpg)
Exelixis to Webcast Fireside Chats as Part of Virtual Investor Conferences in November and December
November 03, 2021
From Exelixis, Inc.
Via Business Wire
Tickers
EXEL
![](https://mms.businesswire.com/media/20211102006271/en/610803/5/exelixis_id_rgb_2c.jpg)
Exelixis Announces Third Quarter 2021 Financial Results and Provides Corporate Update
November 02, 2021
From Exelixis, Inc.
Via Business Wire
Tickers
EXEL
![](https://mms.businesswire.com/media/20211019006111/en/610803/5/exelixis_id_rgb_2c.jpg)
Exelixis to Release Third Quarter 2021 Financial Results on Tuesday, November 2, 2021
October 19, 2021
From Exelixis, Inc.
Via Business Wire
Tickers
EXEL
![](https://mms.businesswire.com/media/20211014005548/en/916118/5/storm_therapeutics_logo.jpg)
![](https://mms.businesswire.com/media/20211014005549/en/828929/4/3960986_Aurigene_logo.jpg)
![](https://mms.businesswire.com/media/20210920005331/en/611316/5/Exelixis_Logo_JPG.jpg)
![](https://mms.businesswire.com/media/20210918005010/en/611316/5/Exelixis_Logo_JPG.jpg)
![](https://mms.businesswire.com/media/20210917005517/en/611316/5/Exelixis_Logo_JPG.jpg)
![](https://mms.businesswire.com/media/20210915006158/en/611316/5/Exelixis_Logo_JPG.jpg)
![](https://mms.businesswire.com/media/20210906005262/en/610803/5/exelixis_id_rgb_2c.jpg)
Exelixis Statement on the Passing of Two Senior Executives
September 06, 2021
From Exelixis, Inc.
Via Business Wire
Tickers
EXEL
![](https://mms.businesswire.com/media/20210901005866/en/610803/5/exelixis_id_rgb_2c.jpg)
Exelixis to Webcast Fireside Chats as Part of Virtual Investor Conferences in September
September 01, 2021
From Exelixis, Inc.
Via Business Wire
Tickers
EXEL
![](https://mms.businesswire.com/media/20210825005760/en/611316/5/Exelixis_Logo_JPG.jpg)
![](https://mms.businesswire.com/media/20210816005189/en/899259/5/Invenra_logo.jpg)
Exelixis and Invenra Expand Collaboration to Discover and Develop Novel Biologics in Oncology
August 16, 2021
From Exelixis, Inc.
Via Business Wire
Tickers
EXEL
![](https://mms.businesswire.com/media/20210805006063/en/610803/5/exelixis_id_rgb_2c.jpg)
Exelixis Announces Second Quarter 2021 Financial Results and Provides Corporate Update
August 05, 2021
From Exelixis, Inc.
Via Business Wire
Tickers
EXEL
![](https://mms.businesswire.com/media/20210805005256/en/611316/5/Exelixis_Logo_JPG.jpg)
![](https://mms.businesswire.com/media/20210722005638/en/610803/5/exelixis_id_rgb_2c.jpg)
![](https://mms.businesswire.com/media/20210708005288/en/610803/5/exelixis_id_rgb_2c.jpg)
Exelixis to Present at the Virtual William Blair Biotech Focus Conference on July 15, 2021
July 08, 2021
From Exelixis, Inc.
Via Business Wire
Tickers
EXEL
![](https://mms.businesswire.com/media/20210618005282/en/610803/5/exelixis_id_rgb_2c.jpg)
Exelixis Chief Medical Officer Gisela M. Schwab, M.D., to Take Medical Leave of Absence
June 18, 2021
From Exelixis, Inc.
Via Business Wire
Tickers
EXEL
![](https://mms.businesswire.com/media/20210614005062/en/611316/5/Exelixis_Logo_JPG.jpg)
![](https://mms.businesswire.com/media/20210604005101/en/611316/5/Exelixis_Logo_JPG.jpg)
![](https://mms.businesswire.com/media/20210604005061/en/611316/5/Exelixis_Logo_JPG.jpg)
![](https://mms.businesswire.com/media/20210604005087/en/611316/5/Exelixis_Logo_JPG.jpg)
![](https://mms.businesswire.com/media/20210526006091/en/610803/5/exelixis_id_rgb_2c.jpg)
![](https://mms.businesswire.com/media/20210524005761/en/611316/5/Exelixis_Logo_JPG.jpg)
![](https://mms.businesswire.com/media/20210506006204/en/610803/5/exelixis_id_rgb_2c.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.